Navigation Links
New mechanism underlying pain found

Researchers at Johnson & Johnson Pharmaceutical Research & Development (J&JPRD) today announced that they have discovered a new molecular mechanism that may underlie neuropathic pain. The clearer understanding of the root-cause of chronic neuropathic pain, and the preclinical validation of new targets for pharmaceutical therapies shown in this research, together present an opportunity for the development of new ways to treat the severe pain associated with such common conditions or diseases as sciatica, diabetic neuropathy and shingles.

This research was presented at Neuroscience 2006, the annual meeting of the Society for Neuroscience.

Neuropathic pain, or the spontaneous pain and abnormal sensitivity following a nerve injury, typically results from a traumatic injury, an infection or disease, or surgery, and can persist long after the initial injury has healed. Millions of people worldwide suffer some form of neuropathic pain, and the current treatment options are limited or inadequate for many people. The research presented today suggests that the persistent pain may be caused by specific types of ion channels, called "pacemaker channels," which initiate a constant and rhythmic transmission of pain signals to the brain, rhythmically similar to those generated by pacemaker cells that regulate one's heart rate.

"What we have shown in our early preclinical research is that we can inhibit the inappropriate neuronal activity and resulting sensitivity that follows nerve injury," said Alan Wickenden, Ph.D., Research Fellow in the Pain and Related Disorders Team at J&JPRD. "Trauma to nerves and the tissues that surround them seems to trigger a complicated cascade of events that results in an increase in the activity of these pacemaker ion channels and the resulting transmission of pain signals to the brain. We are encouraged by early evaluations of certain chemical structures that seem to disrupt this rhythmic transmission."
'"/>

Source:Johnson & Johnson Pharmaceutical Research & Development, L.L.C.


Page: 1 2

Related biology news :

1. A new mechanism of regulating RNA degradation
2. Plants, animals share molecular growth mechanisms
3. PET/MRI scans may help unravel mechanisms of prenatal drug damage
4. Researchers discover molecular mechanism that desensitizes us to cold
5. Chemists identify immune system mechanism for methamphetamine binges
6. Key mechanism in genetic inheritance during cell division identified
7. Researchers unlock mechanism creating jigsaw puzzle-like plant cells
8. Mouse gene shows new mechanism behind cardiac infarction in man
9. UCSD research reveals mechanism involved with type of fatal epilepsy
10. Ancient immune defense mechanism is no match for HIV-1
11. Malaria mechanism revealed

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New mechanism underlying pain found

(Date:11/26/2009)...vember 26, 2009) Whitehead researchers have devel...to pinpoint specific genes and proteins used by pa... In most human cell cultures genes are present in... from the mother. Gene inactivation by mutation is...activated, the second copy usually remains active ...
(Date:11/25/2009)...roduced in the stomach, may be used to boost resis...disease, Yale School of Medicine researchers repor...ournal of Neuroscience . , Parkinson,s disease i...an area of the midbrain known as the substantia ni... Reduced production of dopamine in late-stage Par...
(Date:11/25/2009)...R 25, 2009 Soil is the linchpin of the environmen...et. Despite that, many students see soil as "just ...oil science educators are challenged with the task...critical importance of soil in the environment. ,...th science teachers at University of Nebraska-Linc...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 1New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 2New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 3New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 4New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 5New Shape HF 26amp 3B 238482 3B Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting 48399 1New Shape HF 26amp 3B 238482 3B Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting 48399 2New Shape HF 26amp 3B 238482 3B Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting 48399 3Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Car 4580 1
... be exhausting. When fruit flies mate, the females...s when an immune reaction starts. This is shown in...ng in the scientific publication, Journal of Evol...avioral studies and genomic technology, so-called ... show how fruit fly females are affected by mating...
...ase is available in French . , Montreal, Febru... life has been resolved. According to a study publ...ntral scientists have proposed a new theory for ho...aged to self-assemble as a critical step in the ge... is a complex structure it features a clear hierar...
...Observatory of Singapore (EOS) which aspires to be... addressing several of civilisation,s most serious...namis, volcanic eruptions and climate change aims...ocus on Southeast Asia, that could potentially sav...highly anticipated first Research Centre of Excell...
Other Biology News:Life secret exposed: Scientists unlock mystery of molecular machine 2The Earth Observatory of Singapore devoted to the study of earth sciences officially opens 2The Earth Observatory of Singapore devoted to the study of earth sciences officially opens 3
(Date:11/24/2009)...nt bank KTA Capital,s client Neuren Pharmaceutical...le note private placement with a U.S. institutiona...KTA Capital as Neuren,s exclusive placement agent ...PRWEB) November 23, 2009 -- The independent New Yo...ital") has announced that its client Neuren P...
(Date:11/24/2009)...irstCall/ -- Sigma-Aldrich Corporation (Nasdaq: S...nce on Tuesday, December 1st at 1:45 PM GMT in Lon... via live audio broadcast over the Internet availa...com/ . Users can click the "Webcast" icon to acc...gma-Aldrich is a leading Life Science and High Tec...
(Date:11/24/2009)...ewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NG...oping and commercializing novel pain management th...sident and Chief Executive Officer, is scheduled t...Care Conference, to be held December 1-2, 2009 at ...,, Mr. DiTonno and Stephen Ghiglieri, Chief Fin...
(Date:11/24/2009)... been met for patients with advanced-stage, or ...Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris ... global biopharmaceutical company focused on endoc...e efficacy data from a Phase 2 study with its targ...ly AN-152), in patients with advanced or recurrent...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...American Association for Cancer Research ...il 15 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX )...from its,registrational bioequivalence clinical st...American Association for Cancer Research (AACR),An...harmacokinetic,equivalence observed between an emu...
...Trust, Inc.,(NYSE: BMR ) today announced that Mar...ncurrently with the company,s annual meeting of st..., the Ernest W. Hahn Professor of Real Estate Fina...enter for Real Estate at the,University of San Die...rectors since its initial public offering in 2004,...
...ting Late-Breaking Clinical Trials ...IEGO, April 14 ,Medivation, Inc. (Nasdaq: MDVN ) ...2 clinical trial showed that the Company,s novel a... reduce serum levels of prostate specific,antigen ...anded dose group,tested after three months of trea...
Other Biology Technology:ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 2ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 3ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 4ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 5BioMed Realty Trust Announces Retirement of Mark Riedy From Its Board of Directors 2BioMed Realty Trust Announces Retirement of Mark Riedy From Its Board of Directors 3Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients 3
...ip arrays have been developed for affinity capture... ProteinChip chemical surfaces allow differential ...hemical properties. Each chip has eight different ...d the chips are color-coded with a unique hydropho...
Thermal Printer, 120 V from Bio-Rad
...Assay with FAM-Labeled Substrate (green fluorescen...e serine protease activation • No lysing, fix...its utilize cell-permeable, fluorescently labeled ... chymotrypsin-like activity in whole living cells....
...ay systems, known as ChemiArrayTM Mouse Cytokine A...ith current methodologies. Besides the ability to ...nt a more accurate reflection of active cytokine l... and no amplification step is needed. Furthermore,...
Biology Products: